Clinical Research Directory
Browse clinical research sites, groups, and studies.
IMMunological resPonse Assessment afteR Acute iSchemic Stroke Treated With Endovascular Therapy (IMPRESS)
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Summary
IMPRESS study aims to describe the immuno-inflammatory and thrombo-inflammatory profiles during the first 24/36 hours of treatment of patients suffering from AIC treated with TM, and to study the possible impact of these profiles on the functional prognosis at 3 and 12 months of AIC treatment.
Official title: IMMunological resPonse Assessment afteR Acute iSchemic Stroke Treated With Endovascular Therapy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1200
Start Date
2023-02-23
Completion Date
2028-05-23
Last Updated
2026-01-23
Healthy Volunteers
No
Conditions
Interventions
Prospective patient
The immuno-inflammatory and thrombo-inflammatory profiles will be evaluated at inclusion, and at 24 hours +/- 12 hours of the reperfusion treatment.
Locations (1)
Hôpital Fondation Adolphe de Rothschild
Paris, Paris, France